USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
U.S. Botulinum Toxin Emerging Markets
U.S. Botulinum Toxin Emerging Markets
RELEASE DATE
12-Feb-2003
12-Feb-2003
REGION
North America
North America
Research Code: A345-01-00-00-00
SKU: HC00863-NA-MR_04595
$2,450.00
Special Price $1,837.50 save 25 %
In stock
SKU
HC00863-NA-MR_04595
Description
The U.S. Botulinum toxin emerging markets report provides revenue forecasts, market shares, patient and procedure forecasts, market and technology trends, and existing and emerging applications. The market is segmented by product application, namely cosmetic and therapeutic. Within these segments, emphasis is placed on comparing botulinum toxin to other products in non-surgical cosmetic markets, and dystonia, spasticity and pain management markets. Major market challenges, drivers and restraints, and strategic recommendations to overcome market challenges are discussed.
Table of Contents
Executive Summary
- Executive Summary
Overview
- Introduction
- Report Scope and Segmentation
- Current Approved Indications for Botulinum Toxin
- Clinical Trials Involving Botulinum Toxin(s)
- Reimbursement
- Existing and Future Market Participants
Market Dynamics
- Market Drivers (Cosmetic and Therapeutic Segments)
- Market Restraints (Cosmetic and Therapeutic Segments)
- Challenge 1: Limited Product Differentiation Puts Downward Pressure on Prices
- Challenge 2 : Lax Industry Standards Incite More Stringent Regulatory Process Which Impedes Market Growth
- Challenge 3: Lack of Generic Competition Attracts New Entrants and Threatens Market Profit Potential
- Challenge 4 : U.S. Government Actions against Bioterrorism Threaten to Restrict Product Supply
Forecasts and Trends
- Demand Analysis
- Revenue Forecasts
- Market Engineering Analysis
- Market and Technology Trends
- New Technology Developments
Competitive Analysis
- Competitive Structure and Competitor Strategies
- Product Analysis
- Market Share Analysis
Overview
Forecasts and Market Trends
Overview
Forecasts and Market Trends
Popular Topics
The U.S. Botulinum toxin emerging markets report provides revenue forecasts, market shares, patient and procedure forecasts, market and technology trends, and existing and emerging applications. The market is segmented by product application, namely cosmetic and therapeutic. Within these segments, emphasis is placed on comparing botulinum toxin to other products in non-surgical cosmetic markets, and dystonia, spasticity and pain management markets. Major market challenges, drivers and restraints, and strategic recommendations to overcome market challenges are discussed.
| No Index | No |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | A345-01-00-00-00 |
| Is Prebook | No |